ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

LDS BIOTECH ANNOUNCES THE INITIATION OF PHASE I/II CLINICAL TRAIL FOR THE TREAMTEN OF OPIOID USED DISORDER (OUD)

Lyotropic Delivery Systems Ltd. (LDS) in collaboration with American company Ananda Scientific Inc. are proud to announce the approval, by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for the clinical trial evaluating Nantheia™ ATL5, cannabidiol (CBD). The product is ANANDA’s proprietary delivery technology based on licensed LDS technology focusing on clinical development on opioid addiction.

en